Literature DB >> 10801973

A phage integrase directs efficient site-specific integration in human cells.

A C Groth1, E C Olivares, B Thyagarajan, M P Calos.   

Abstract

The integrase from the Streptomyces phage phiC31 carries out efficient recombination between the attP site in the phage genome and the attB site in the host bacterial chromosome. In this paper, we show that the enzyme also functions in human cells. A plasmid assay system was constructed that measured intramolecular integration of attP into attB. This assay was used to demonstrate that in the presence of the phiC31 integrase, precise unidirectional integration occurs with an efficiency of 100% in Escherichia coli and >50% in human cells. This assay system was also used to define the minimal sizes of attB and attP at 34 bp and 39 bp, respectively. Furthermore, precise and efficient intermolecular integration of an incoming plasmid bearing attP into an established Epstein-Barr virus plasmid bearing attB was documented in human cells. This work is a demonstration of efficient, site-specific, unidirectional integration in mammalian cells. These observations form the basis for site-specific integration strategies potentially useful in a broad range of genetic engineering applications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801973      PMCID: PMC18547          DOI: 10.1073/pnas.090527097

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Structural analysis of the actinophage phi C31 attachment site.

Authors:  H Rausch; M Lehmann
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  Replication control of autonomously replicating human sequences.

Authors:  S B Haase; M P Calos
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

Review 4.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

5.  Recombinase-mediated gene activation and site-specific integration in mammalian cells.

Authors:  S O'Gorman; D T Fox; G M Wahl
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

6.  Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase.

Authors:  B Sauer; N Henderson
Journal:  New Biol       Date:  1990-05

7.  Mammalian genomes contain active recombinase recognition sites.

Authors:  B Thyagarajan; M J Guimarães; A C Groth; M P Calos
Journal:  Gene       Date:  2000-02-22       Impact factor: 3.688

8.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

9.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

Authors:  R B DuBridge; P Tang; H C Hsia; P M Leong; J H Miller; M P Calos
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

10.  Transfected DNA is mutated in monkey, mouse, and human cells.

Authors:  J S Lebkowski; R B DuBridge; E A Antell; K S Greisen; M P Calos
Journal:  Mol Cell Biol       Date:  1984-10       Impact factor: 4.272

View more
  181 in total

1.  Cre levels limit packaging signal excision efficiency in the Cre/loxP helper-dependent adenoviral vector system.

Authors:  Philip Ng; Carole Evelegh; Derek Cummings; Frank L Graham
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 2.  Recombinase-directed plant transformation for the post-genomic era.

Authors:  David W Ow
Journal:  Plant Mol Biol       Date:  2002-01       Impact factor: 4.076

3.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells.

Authors:  Susanne Andreas; Frieder Schwenk; Birgit Küter-Luks; Nicole Faust; Ralf Kühn
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

Review 4.  Streptomyces temperate bacteriophage integration systems for stable genetic engineering of actinomycetes (and other organisms).

Authors:  Richard H Baltz
Journal:  J Ind Microbiol Biotechnol       Date:  2011-12-13       Impact factor: 3.346

5.  Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase.

Authors:  B Thyagarajan; E C Olivares; R P Hollis; D S Ginsburg; M P Calos
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

6.  Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.

Authors:  Christopher L Chavez; Annahita Keravala; Jacqueline N Chu; Alfonso P Farruggio; Vanessa E Cuéllar; Jan Voorberg; Michele P Calos
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

7.  Towards integrating vectors for gene therapy: expression of functional bacteriophage MuA and MuB proteins in mammalian cells.

Authors:  F H Schagen; H J Rademaker; S J Cramer; H van Ormondt; A J van der Eb; P van de Putte; R C Hoeben
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

8.  Synapsis and DNA cleavage in phiC31 integrase-mediated site-specific recombination.

Authors:  Matthew C A Smith; Rob Till; Kevin Brady; Panos Soultanas; Helena Thorpe; Margaret C M Smith
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

Review 9.  Biomedical and agricultural applications of animal transgenesis.

Authors:  Alison J Thomson; Jim McWhir
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

10.  In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium.

Authors:  Sylvestre Marillonnet; Anatoli Giritch; Mario Gils; Romy Kandzia; Victor Klimyuk; Yuri Gleba
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.